Verve Therapeutics pauses enrollment in early-stage gene therapy study for high cholesterol levels By Reuters
[ad_1] (Reuters) -Verve Therapeutics said on Tuesday that it had paused enrollment for an early-stage study testing its experimental gene editing therapy for high cholesterol...
US FDA approves Merck’s therapy for rare lung condition By Reuters
[ad_1] By Leroy Leo and Michael Erman (Reuters) -The U.S. Food and Drug Administration on Tuesday approved Merck’s treatment for adults with high blood pressure...
Acelyrin reports positive early trial results for TED therapy By Investing.com
[ad_1] © Reuters. LOS ANGELES – Acelyrin Inc. (NASDAQ:SLRN), a biopharmaceutical company specializing in immunology treatments, has announced promising early results from its Phase 1/2...
Orchestra BioMed reports sustained blood pressure reduction with AVIM therapy By Investing.com
[ad_1] © Reuters. NEW HOPE, Pa. – Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO), a biomedical company, has announced new data on the long-term effectiveness of its...
Legend Biotech’s CARVYKTI therapy for myeloma gets positive CHMP opinion By Investing.com
[ad_1] © Reuters. SOMERSET, N.J. – Legend Biotech Corporation (NASDAQ: LEGN), a cell therapy company, announced that the Committee for Medicinal Products for Human Use...
Puma Biotech starts phase II trial for lung cancer therapy By Investing.com
[ad_1] © Reuters. LOS ANGELES – Puma Biotechnology, Inc. (NASDAQ: NASDAQ:) has commenced a Phase II clinical trial to evaluate the efficacy of its drug...
Marketmind: U.S. retail therapy as China funk deepens By Reuters
[ad_1] © Reuters. FILE PHOTO: Raindrops hang on a sign for Wall Street outside the New York Stock Exchange in Manhattan in New York City,...
What happens when a $2 million gene therapy is not enough By Reuters
[ad_1] 5/5 © Reuters. Elizabeth Kutschke spends time at the park with her 2-year-old son, Ben, who was diagnosed with spinal muscular atrophy, an inherited...
Mesoblast shares tank after US FDA rejects cell therapy for children By Reuters
[ad_1] © Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020....
U.S. FDA approves bluebird bio’s gene therapy for a rare neurological disorder By Reuters
[ad_1] © Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020....